Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 22
Filter
1.
Biodegradation ; 34(3): 253-262, 2023 06.
Article in English | MEDLINE | ID: mdl-36797384

ABSTRACT

In the present study, the potential inhibitory effect of biologically pre-treated vegetable tannery wastewater (TW) on anammox granular biomass was evaluated. Beside high organic and chemicals load, vegetable TW are characterised by high salinity and high tannins concentration, the latter belonging to a group of bio-refractory organic compounds, potentially inhibitory for several bacterial species. Recalcitrant tannin-related organic matters and salinity were selected as the two potential inhibitory factors and studied either for their separate and combined effect. Parallel batch tests were performed, with biomass acclimated and non-acclimated to salinity, testing three different conditions: non-saline control test with non-acclimated biomass (CT); saline control test with acclimated biomass (SCT); vegetable tannery wastewater test with acclimated biomass (TWT). Compared with non-saline CT, the specific anammox activity in tests SCT and TWT showed a reduction of 28 and 14%, respectively, suggesting that salinity, at conductivity values of 10 mS/cm (at 25 °C), was the main impacting parameter. As a general conclusion, the study reveals that there is no technical limitation for the application of the anammox process to vegetable TW, but preliminary biomass acclimation as well as regular biomass activity monitoring is recommended in case of long-term applications. To the best of our knowledge, this is the first work assessing the impact of vegetable TW on anammox biomass.


Subject(s)
Ammonium Compounds , Wastewater , Vegetables , Bioreactors/microbiology , Nitrogen , Biomass , Denitrification , Anaerobic Ammonia Oxidation , Oxidation-Reduction , Anaerobiosis
2.
Carbohydr Polym ; 254: 117304, 2021 Feb 15.
Article in English | MEDLINE | ID: mdl-33357871

ABSTRACT

In this work we present a simple, inexpensive, and easily scalable industrial paper process to prepare sheets of conductive cellulose fibers coated with polyanilines. First, bare fibers were coated by in situ oxidative polymerization of polyaniline then, the resulting composite fibers were used to fabricate electroactive sheets. The resistivity of the sheets is 14 ± 1 Ω sq-1, a value around 1000 times lower than those reported in literature. The superior electronic proprieties of the sheets were demonstrated by assembling a capacitive touch sensor device with optimized geometry. The touch sensor shows an increase of 3-4 % of the starting electric capacity after compression and a fast response time of 52 ms. To our knowledge this is the first time that a device is prepared in this way and therefore, the herein presented results can bring an significant improvement in the development of low-cost, green and high-tech electronic devices.

3.
Minerva Pediatr ; 66(3): 177-86, 2014 Jun.
Article in English | MEDLINE | ID: mdl-24826974

ABSTRACT

AIM: The study was aimed at obtaining knowledge about mothers' experiences of preterm birth. The objective of the study is to explore coping strategies and self- perceived parental competence, in mothers of infant born moderately and severely preterm and admitted to the Neonatal Intensive Care Unit (NICU). METHODS: The study involved a group of 16 mothers of moderately preterm children (weeks' gestational age: mean=34, SD=2 and birth weight: mean=2000 g, SD=200 g) and a group of 14 mothers of severely preterm children (weeks' gestational age: mean=29, SD=2 and birth weight: mean=1700 g, SD=350 g). The following instruments were used with mothers to investigate focus areas of research: Coping Orientation to the Problems Experienced-New Italian Version (COPE-NVI), to analyse coping strategies of mothers, and a Q-sort, a self report on maternal competence. RESULTS: Data did not show statistically significant differences between the two groups of mothers, both in regard to considered coping strategies (social support, avoidance, problem focused orientation, transcendent orientation, positive aptitude), and the indicators of maternal self-perceived competence (coping, scaffolding, caregiving) (Mann-Whitney U test(n1=16 and n2=14)>0.05). CONCLUSION: This study, highlighting the lack of differences between the two groups of mothers involved, seems to point out that, beyond the levels of prematurity, the condition of preterm birth itself is precisely the main stressor factor for mothers.


Subject(s)
Adaptation, Psychological , Infant, Premature , Mother-Child Relations/psychology , Mothers/psychology , Parenting , Adult , Female , Humans , Infant, Newborn , Male
4.
Diabetes Obes Metab ; 16(4): 376-80, 2014 Apr.
Article in English | MEDLINE | ID: mdl-24251534

ABSTRACT

The combined glucose-lowering effect of exenatide and dapagliflozin has not yet been studied. We investigated this combination (single-dose or 4-week dosing) in diabetic ob/ob mice. Vehicle-corrected basal glucose showed greater reduction 1 h following exenatide + dapagliflozin than with exenatide or dapagliflozin alone, and stayed significantly lower for all groups versus vehicle over 3 h. During an oral glucose tolerance test, glucose excursion (30 min post-dose) was significantly lower for exenatide + dapagliflozin versus exenatide or dapagliflozin, or vehicle. Exenatide + dapagliflozin and exenatide, but not dapagliflozin alone, reduced glucose excretion over 24 h versus vehicle. After dosing for 4 weeks, exenatide, dapagliflozin and exenatide + dapagliflozin similarly decreased haemoglobin A1c (HbA1c). Body weight was reduced only with exenatide or exenatide + dapagliflozin. The glomerular filtration rate was similar with exenatide, dapagliflozin and vehicle, and increased with exenatide + dapagliflozin. Optimized combinatorial dosing of these antidiabetic agents may provide additive glucose lowering in type 2 diabetes mellitus.


Subject(s)
Diabetes Mellitus, Experimental/drug therapy , Glucosides/pharmacology , Hypoglycemic Agents/pharmacology , Peptides/pharmacology , Venoms/pharmacology , Animals , Benzhydryl Compounds , Biomarkers/blood , Blood Glucose/drug effects , Blood Glucose/metabolism , Body Weight , Diabetes Mellitus, Experimental/blood , Exenatide , Glycated Hemoglobin/drug effects , Glycated Hemoglobin/metabolism , Male , Mice , Mice, Inbred NOD
5.
Minerva Pediatr ; 62(1): 43-50, 2010 Feb.
Article in Italian | MEDLINE | ID: mdl-20212397

ABSTRACT

AIM: The contribution reports on a pre-test pilot study, based on the single-case method (N>1 and N=1 one by one), aimed to investigate whether resilience factors regards self-narrative representation, self-esteem and their likely correlations in child suffering from tumour. METHODS: The administration of specific investigation instruments (TMA - multidimensional self-esteem test, and a narrative inquiry framed on purpose) has been planned by the survey. The participating subjects set up a group of 7 children, 10 year olds, suffering from tumour. The individuation of such subjects has been carried out in terms of some "drawing variables" such as the existence of tumour, its diagnosis (12 months before commencing the research), the continuity of medical treatment and the lack of terminal stage of disease. RESULTS: The study has highlighted the lack of a statistically remarkable impairment of self-narrative and self-esteem in children suffering from tumour belonging to the reference group. These levels of self-narrative and self-esteem are possible resilience factors in children suffering from tumour. CONCLUSION: The acquired data about specific resilience elements in child suffering from tumor directs to research with national and international sample.


Subject(s)
Neoplasms/psychology , Self Concept , Child , Humans , Narration , Pilot Projects , Resilience, Psychological
6.
Minerva Pediatr ; 56(4): 431-44, 2004 Aug.
Article in Italian | MEDLINE | ID: mdl-15457141

ABSTRACT

AIM: The paper reports research on the subject of "Overcoming the illness risk in the School in Hospital service" the aim of which was to monitor this particular service so as to assess whether or not the activities proposed are directed by the model of overcoming inherent risks as defined and reported here. Four research directions were taken to verify the hypothesis whereby the service takes on a supportive-transformative value which enables the hospitalized child to study through his/her illness and is thus able to develop by activating support, protection and diagnosis functions. METHODS: The investigation was carried out using the single case methodology which provided for continuous observation lasting for the entire hospital period in the paediatric wards of 2 hospital in Sicily. The research involved 58 children aged between 7 and 12; chronically ill or long-stay patients, and 100 mothers of hospitalized children. The research also observed the effects of the intervention activated by "School in Hospital" on the child and on his reference models. Various instruments of an observational, projective and psycho-social investigation type were utilized in relation to the 2 main subjects of the research, the development outcomes on the subjects involved and the activities proposed by the service. RESULTS: The overall results confirm the supportive-transformative value of the "School in Hospital" service. CONCLUSIONS: The data obtained suggest that the service should be promoted within hospital structures as a specific form of the caring approach.


Subject(s)
Child, Hospitalized , Hospitals , Schools , Child , Humans , Surveys and Questionnaires
7.
Cardiovasc Drugs Ther ; 13(4): 315-24, 1999 Jul.
Article in English | MEDLINE | ID: mdl-10516867

ABSTRACT

The VISOR is a double blind, randomized, placebo-controlled study aimed to assess the effects of early and prolonged administration of verapamil on the left ventricular geometry and diastolic function in patients with anterior acute myocardial infarction treated with thrombolysis. Patients with heart failure or ejection fraction < 45% were excluded. Within 12 hours from starting thrombolysis, 70 patients were given verapamil (5 mg/hour intravenously for the first 24 hours, followed by 120 mg t.i.d. perorally for 6 months) or equivalent placebo. Echocardiograms were performed on admittance, before discharge, after 3 months and 6 months. The following parameters were calculated: left ventricular volumes, ejection fraction, sphericity index, early (E) and late (A) transmitral peak flow velocities and time-velocity integrals with their ratios, deceleration time and half-time of E, isovolumic relaxation time (IVRT), and non-invasive time constant of ventricular relaxation (tau). The basal and the last available parameters were considered for statistical analysis. The effects of the treatment on the left ventricular volumes, ejection fraction, and sphericity index were not statistically relevant. Conversely, a reduction of E/A ratio (P < .05) and increases of A integral (P < .01), deceleration time and half-time of E, IVRT and tau (P < .05) were found in the placebo group and not in the verapamil group. No significant changes in the blood pressure, heart rate, PQ interval, and biochemical parameters were observed in the two groups. In conclusion, in patients with a thrombolysed anterior acute myocardial infarction and preserved systolic function, verapamil can prevent alterations of the diastolic function in absence of effect on ventricular remodelling, and has a good safety profile.


Subject(s)
Diastole/drug effects , Hemodynamics/drug effects , Myocardial Infarction/pathology , Ventricular Remodeling/drug effects , Verapamil/therapeutic use , Calcium Channel Blockers/administration & dosage , Calcium Channel Blockers/therapeutic use , Double-Blind Method , Echocardiography , Echocardiography, Doppler , Electrocardiography/drug effects , Female , Humans , Male , Middle Aged , Time Factors , Verapamil/administration & dosage
8.
J Cell Biol ; 112(2): 191-201, 1991 Jan.
Article in English | MEDLINE | ID: mdl-1988457

ABSTRACT

We have examined the chromatin structure of centromere regions from the fission yeast Schizosaccharomyces pombe. The large and complex centromere regions of the S. pombe chromosomes encompass many kilobase pairs of DNA and contain several classes of tandemly repeated DNA sequences. The repeated sequences are further organized into a large inverted repeat flanking a central core, a conserved structural feature among all three centromeres in S. pombe. The nucleosomal configuration of the centromere regions is nonuniform and highly varied. Most of the centromere-specific repeated DNA sequences are packaged into nucleosomes typical of bulk chromatin. However, the central core and core-associated repeated sequences from the centromere regions of chromosomes I (cen1) and II (cen2), when present in S. pombe, show an altered chromatin structure, with little or no evidence of regular nucleosomal packaging. The atypical chromatin organization of the cen2 central core is not due to transcription, as no transcripts from this region were detected. These same DNA sequences, however, are packaged into nucleosomes typical of bulk chromatin when present in a nonfunctional environment on a minichromosome in the budding yeast Saccharomyces cerevisiae. Because the cen2 central core sequences themselves do not preclude regular nucleosomal packaging, we speculate that in S. pombe they constitute a specialized site of kinetochore protein assembly. The atypical nucleosomal pattern of the cen2 central core remains constant during the cell cycle, with only minor differences observed for some sequences. We propose that the unusual chromatin organization of the core region forms the basis of a higher order structural differentiation that distinguishes the centromere from the chromosome arms and specifies the essential structure for centromere function.


Subject(s)
Centromere/ultrastructure , Chromatin/ultrastructure , Schizosaccharomyces/genetics , Blotting, Northern , Cell Cycle , DNA, Fungal/genetics , Nucleosomes/ultrastructure , Repetitive Sequences, Nucleic Acid , Restriction Mapping , Schizosaccharomyces/cytology , Transcription, Genetic
9.
Semin Thromb Hemost ; 15(4): 464-9, 1989 Oct.
Article in English | MEDLINE | ID: mdl-2814516

ABSTRACT

The results of this preliminary clinical trial confirm the thrombolytic effect of defibrotide demonstrated in preclinical models; demonstrate the positive influence of the product on the natural history of early AMI; suggest that the optimal dosage range should include not less than 1.6 gm of defibrotide during the first hour of treatment; and justify further commitment in the study of defibrotide also beyond the scope of treating AMI.


Subject(s)
Fibrinolytic Agents/therapeutic use , Myocardial Infarction/drug therapy , Polydeoxyribonucleotides/therapeutic use , Dose-Response Relationship, Drug , Drug Administration Schedule , Drug Evaluation , Drug Therapy, Combination , Fibrinolytic Agents/administration & dosage , Fibrinolytic Agents/adverse effects , Humans , Myocardial Infarction/pathology , Myocardial Reperfusion , Necrosis , Polydeoxyribonucleotides/administration & dosage , Polydeoxyribonucleotides/adverse effects
10.
Clin Ter ; 128(3): 183-9, 1989 Feb 15.
Article in Italian | MEDLINE | ID: mdl-2470545

ABSTRACT

Flecainide (F) is a new antiarrhythmic agent recently introduced into clinical practice. The above study was aimed at evaluating its intravenous (iv) pharmacokinetics in patients (pts) with acute myocardial infarction (AMI) on 1st and 2nd day, complicated by complex ventricular premature beats (VPBs). 2 mg/kg F was given iv as bolus injection, followed by 300 mg/24 hrs iv infusion. Plasma F values were evaluated by HPLC. Plasma F levels increased progressively, in a non uniform but predictable manner: in pts with large AMI and cardiac failure, F plasma levels, although remaining within the therapeutic range, were greatly increased after the 2nd hour (P less than 0.05) in comparison with pts without cardiac insufficiency. Negative side effects, both cardiac and extracardiac, were not observed: F appeared a handy and effective agent in post-AMI arrhythmias, especially when plasma drug levels are controlled; plasma F level monitoring is anyway recommended in pts with cardiac failure, owing to the wide interindividual variations.


Subject(s)
Arrhythmias, Cardiac/drug therapy , Flecainide/pharmacokinetics , Myocardial Infarction/complications , Adult , Aged , Arrhythmias, Cardiac/etiology , Cardiac Complexes, Premature/drug therapy , Cardiac Complexes, Premature/etiology , Female , Flecainide/administration & dosage , Flecainide/blood , Heart Ventricles , Humans , Infusions, Intravenous , Male , Middle Aged
11.
Proc Natl Acad Sci U S A ; 86(2): 577-81, 1989 Jan.
Article in English | MEDLINE | ID: mdl-2643117

ABSTRACT

The centromere DNAs from chromosomes I and III of Schizosaccharomyces pombe have been cloned in an artificial chromosome vector in both budding and fission yeasts. In S. pombe, synthetic linear and circular minichromosomes containing an intact centromere are stable mitotically and behave as independent genetic linkage groups that segregate properly through meiosis. These experiments present a general strategy for the isolation of centromeres from other organisms.


Subject(s)
Centromere/physiology , Chromosomes, Fungal/physiology , DNA, Fungal/genetics , Saccharomycetales/genetics , Schizosaccharomyces/genetics , Cloning, Molecular , Genetic Vectors , Mitosis , Plasmids , Saccharomyces cerevisiae/genetics
13.
Alcohol ; 4(6): 477-80, 1987.
Article in English | MEDLINE | ID: mdl-3435636

ABSTRACT

A fluorigenic high performance liquid chromatographic (HPLC) assay for the determination of acetaldehyde in plasma and hemoglobin-associated acetaldehyde is described. The assay is based on the reaction of acetaldehyde with two molecules of 1,3-cyclohexanedione in the presence of ammonium ion to form a fluorescent species followed by reverse phase HPLC separation of specific aldehyde derived compounds. The assay is specific; and has sensitivity in the picomole range, with intraassay precision of less that 3.5% and interassay precision of less than 15%. The total run time is less than 6 minutes on HPLC. Hemoglobin-associated acetaldehyde levels were higher than the levels found in plasma. Endogenous levels of acetaldehyde in samples obtained from teetotalers were found to be 0.43 +/- 0.04 (S.D.) microM in plasma and 74.2 +/- 16.1 nmol/g protein as hemoglobin-associated acetaldehyde. The levels of both plasma acetaldehyde and hemoglobin-associated acetaldehyde were significantly higher in patients reporting to a center for alcohol treatment than the levels encountered in teetotalers.


Subject(s)
Acetaldehyde/blood , Alcoholism/blood , Hemoglobins/analysis , Temperance , Chromatography, High Pressure Liquid , Fluorometry , Humans , Microchemistry/methods
15.
G Ital Cardiol ; 14(5): 360-6, 1984 May.
Article in Italian | MEDLINE | ID: mdl-6147292

ABSTRACT

The need to treat severe and repetitive arrhythmias which are often resistant to treatment with single different drugs has led to an increasing interest towards associations of antiarrhythmic drugs. The advantages of this associations could be: enhancing effect of different pharmacological properties, synergism, reduction of doses and side-effects. The risks are: induction or aggravation of excitability and conduction disturbances, impairment of contractility, hypotension, interaction with digoxin. This study describes our experience in using associations of antiarrhythmic drugs of different classes (IA + II, IA + III, IB + III) or of the same class (IA). We also report our preliminary results with the use of Propafenon-Amiodarone association in the acute treatment of electrophysiologically induced ventricular tachycardias and in the chronic treatment of repetitive and symptomatic ventricular tachycardias. Our experience demonstrates that the association of antiarrhythmic drugs is effective in the treatment of severe and repetitive arrhythmias only if the patients are carefully selected and the risks of unwelcome electrophysiological actions and side-effects are taken into account.


Subject(s)
Anti-Arrhythmia Agents/therapeutic use , Adrenergic beta-Antagonists/therapeutic use , Amiodarone/therapeutic use , Digoxin/therapeutic use , Drug Therapy, Combination , Humans , Mexiletine/therapeutic use , Propafenone , Propiophenones/therapeutic use , Quinidine/therapeutic use
20.
Immunogenetics ; 10(1): 67-82, 1980.
Article in English | MEDLINE | ID: mdl-7409862

ABSTRACT

In comparing the tryptic peptide maps of the H-2L and H-2D glycoprotein antigens isolated from NP-40 lysates of RADA1 (H-2 alpha) leukemic cells, no more than 37% of the observed arginine-containing tryptic peptides are found to be homologous. Thus, the primary amino-acid sequences of these two antigens are probably less than 90% homologous. This constitutes the strongest evidence to date that the MHC-linked H-2L region encodes H-2L antigens separately from the H-2D region, even though H-2L antigens bear D-end-associated antigenic determinants of the H-2.28 family. The anti-H-2.28 alloantiserum (k X r anti h2) used to precipitate H-2L antigens in this investigation was the NIH contract antiserum D28b. As the tryptic peptide maps also suprisingly revealed, D28b precipitates H-2D antigens as well and, thus, anti-H-2.4 immunoadsorbants were employed to isolate H-2L free of H-2D antigens. In light of the dual specificity of D28b, its reactivity with BALB/c-H-2dm2 mutant cells was re-examined. Even though mutant lymphocytes, which lack H-2L but not H-2D antigens, are not cytotoxically lysed by D28b (as are parental H-2d cells), D28b appears to precipitate H-2D antigens from NP-40 extracts of mutant splenocytes.


Subject(s)
Genetic Code , Genetic Linkage , H-2 Antigens/genetics , Major Histocompatibility Complex , Animals , Chemical Precipitation , Chromosome Mapping , Cytotoxicity, Immunologic , Electrophoresis, Polyacrylamide Gel , Immunosorbents , Mice , Mice, Inbred BALB C , Peptides , Trypsin/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL